Clinical Trial Update: Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial for locally advanced or metastatic non-small cell lung cancer completed evaluating two regimens: cisplatin with docetaxel and oxalip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Krankenhaus Nordwest | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED